^
BIOMARKER:

PTEN mutation

i
Other names: PTEN, Phosphatase and tensin homolog, Mutated In Multiple Advanced Cancers 1, Phosphatase And Tensin Homolog, Phosphatidylinositol 3,4,5-Trisphosphate 3-Phosphatase And Dual-Specificity Protein Phosphatase PTEN, MMAC1, TEP1, MMAC1 Phosphatase And Tensin Homolog Deleted On Chromosome 10, Mitochondrial Phosphatase And Tensin Protein Alpha, Phosphatase And Tensin-Like Protein, Protein Tyrosine Phosphatase, Mitochondrial PTENalpha, PTENbeta, PTEN1, CWS1, GLM2, MHAM
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
PTEN mutation
Breast Cancer
TAS-117
Sensitive
:
C4
ESMO 2022 - 3 weeks - (New C4)
PTEN mutation
Triple Negative Breast Cancer
RG7440
Sensitive
:
B
PTEN mutation
Prostate Cancer
bicalutamide
Sensitive
:
B
PTEN mutation
Colorectal Cancer
panitumumab
Sensitive
:
B
PTEN mutation
Breast Cancer
GDC-0032
Resistant
:
B
PTEN mutation
Estrogen Receptor Positive Breast Cancer
AZD5363
Sensitive
:
C2
PTEN mutation
Glioblastoma
atezolizumab + RG7440
Sensitive
:
C3
PTEN mutation
Triple Negative Breast Cancer
pembrolizumab
Resistant
:
C3
PTEN mutation
Triple Negative Breast Cancer
atezolizumab
Resistant
:
C3
PTEN mutation
Endometrial Cancer
LY3023414
Sensitive
:
C3
PTEN mutation
Hormone Receptor Positive Breast Cancer
alpelisib
Resistant
:
C3
PTEN mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
C3
PTEN mutation
Colorectal Cancer
cetuximab
Resistant
:
C3
PTEN mutation
Prostate Cancer
abiraterone acetate + RG7440
Resistant
:
C3
PTEN mutation
Melanoma
Immunotherapy
Resistant
:
C3
PTEN mutation
Melanoma
pembrolizumab + GSK2636771
Sensitive
:
C3
PTEN mutation
Prostate Cancer
enzalutamide capsule + CC-115
Sensitive
:
C3
PTEN mutation
Melanoma
vemurafenib
Resistant
:
C4
PTEN mutation
Pancreatic Cancer
MK-2206
Sensitive
:
C4
PTEN mutation
Glioblastoma
MLN4924
Resistant
:
D
PTEN mutation
Glioma
MLN4924
Resistant
:
D
PTEN mutation
Prostate Cancer
dasatinib + AZD8055
Sensitive
:
D
PTEN mutation
Colorectal Cancer
PARP inhibitor
Resistant
:
D
PTEN mutation
Breast Cancer
CB-228
Sensitive
:
D
PTEN mutation
Endometrial Cancer
AZD6482
Resistant
:
D
PTEN mutation
Endometrial Cancer
GSK2636771
Resistant
:
D
PTEN mutation
Endometrial Cancer
GDC-0941
Sensitive
:
D
PTEN mutation
Endometrial Cancer
RTB101
Sensitive
:
D
PTEN mutation
Endometrial Cancer
A66
Resistant
:
D
PTEN mutation
Endometrial Cancer
A66 + AZD6482
Sensitive
:
D
PTEN mutation
Endometrial Cancer
GSK2636771 + A66
Sensitive
:
D
PTEN mutation
Endometrial Cancer
TGX-221
Sensitive
:
D
PTEN mutation
Endometrial Cancer
temsirolimus
Sensitive
:
D